Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.

Item
http://www.wikidata.org/entity/Q34093830
Therapeutic Use of Native and Recombinant EnterovirusesIs a multivalent hand, foot, and mouth disease vaccine feasible?EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseasesAn attenuated coxsackievirus b3 vector: a potential tool for viral tracking study and gene deliveryThe antiviral effect of jiadifenoic acids C against coxsackievirus B3.Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.In vitro molecular characterization of RNA-proteins interactions during initiation of translation of a wild-type and a mutant Coxsackievirus B3 RNAs.A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study.MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis.Streptomyces lavendulaeProtease Inhibitor: Purification, Gene Overexpression, and 3-Dimensional Structure
P2860

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.

Item
http://www.wikidata.org/entity/Q34093830
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of attenuated ...... n as live-attenuated vaccines.
@ast
Characterization of attenuated ...... n as live-attenuated vaccines.
@en
Characterization of attenuated ...... n as live-attenuated vaccines.
@nl
type
label
Characterization of attenuated ...... n as live-attenuated vaccines.
@ast
Characterization of attenuated ...... n as live-attenuated vaccines.
@en
Characterization of attenuated ...... n as live-attenuated vaccines.
@nl
prefLabel
Characterization of attenuated ...... n as live-attenuated vaccines.
@ast
Characterization of attenuated ...... n as live-attenuated vaccines.
@en
Characterization of attenuated ...... n as live-attenuated vaccines.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Characterization of attenuated ...... n as live-attenuated vaccines.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921